as 08-01-2025 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Upcoming Earnings Alert:
Get ready for potential market movements as Becton Dickinson and Company BDX prepares to release earnings report on 07 Aug 2025.
Founded: | 1897 | Country: | United States |
Employees: | N/A | City: | FRANKLIN LAKES |
Market Cap: | 49.0B | IPO Year: | 1962 |
Target Price: | $231.50 | AVG Volume (30 days): | 3.0M |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.16 | EPS Growth: | 14.07 |
52 Week Low/High: | $163.33 - $251.99 | Next Earning Date: | 08-07-2025 |
Revenue: | $20,867,000,000 | Revenue Growth: | 5.84% |
Revenue Growth (this year): | 9.24% | Revenue Growth (next year): | 4.88% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Shan David | BDX | EVP and Chief ISC Officer | Jun 2 '25 | Sell | $171.19 | 1,166 | $199,607.54 | 4,575 |
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
PR Newswire
3 days ago
PR Newswire
25 days ago
Simply Wall St.
a month ago
StockStory
a month ago
StockStory
a month ago
Insider Monkey
a month ago
Morningstar Research
a month ago
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.